Virax Biolabs Group Ltd (VRAX) stock
VRAXNasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends March 31
$0.45−0.00 (-0.65%)
Close on Nov 17, 2026Market cap $257.81KP/E –Yield –
Virax Biolabs pe ratio
The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.
No pe ratio figures for Virax Biolabs
Virax Biolabs has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.
See a number that looks wrong?